Evidence map›Paper›PMID 41971066›Full record

ReviewMolecular therapy. Nucleic acids2026

Modulating G-quadruplexes for therapeutic intervention: Structural diversity, stability, and emerging nucleic-acid-based strategies.

Mariia Sokulska, Maria Nalewaj, Tomasz Czapik, Marta Rachwalak, Marta Szabat

Abstract readReview
In one paragraph

Review in Molecular therapy. Nucleic acids, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mariia SokulskaInstitute of Bioorganic Chemistry, Polish Academy of Sciences, Noskowskiego 12/14, 61-704 Poznan, Poland.
Maria NalewajInstitute of Bioorganic Chemistry, Polish Academy of Sciences, Noskowskiego 12/14, 61-704 Poznan, Poland.
Tomasz CzapikBiomolecular Division of Biomolecular and Cellular Medicine, Department of Laboratory Medicine, Karolinska Institutet, ANA Futura, Alfred-Nobels-Allé 8, 14152 Huddinge, Sweden.
Marta RachwalakInstitute of Bioorganic Chemistry, Polish Academy of Sciences, Noskowskiego 12/14, 61-704 Poznan, Poland.
Marta SzabatInstitute of Bioorganic Chemistry, Polish Academy of Sciences, Noskowskiego 12/14, 61-704 Poznan, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

G-quadruplexes (G4s) are non-canonical nucleic acid structures formed by guanine-rich DNA or RNA sequences. The G4s are formed by planar G-tetrads and stabilized by monovalent metal cations such as potassium or sodium. The structural diversity of G4s arises from differences in strand orientation, loop arrangement, and molecularity, leading to multiple topologies. The length of guanine tracts (G-tracts) and the number of strands involved further influence G4 folding, stability, and biological function. G-quadruplexes are commonly found in key genomic regions such as telomeres, promoters, and untranslated regions, where they play important roles in regulating fundamental biological processes, including replication, transcription, and translation. In this review, we summarize the molecular factors influencing G4 formation and stability. We also discuss recent advances in therapeutic strategies for targeting G-quadruplexes. Particular attention is given to antisense oligonucleotides (ASOs), ASO-ligand conjugates, peptide nucleic acids (PNAs), and PNA-conjugates as chemical tools for selective G4 recognition and modulation. We highlight the potential of nucleic-acid-based approaches for molecular therapeutics, including applications in anticancer and antiviral treatments.

Indexed as

antisense oligonucleotidesconjugatesG4-specific ligandsG-quadruplex stabilityMT: oligonucleotides: therapies and applicationspeptide nucleic acidsRNA/DNA G-quadruplextherapeutic toolsviral genome

Identifiers

PMID41971066
PMCPMC13068845

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.